Colorado to consider state rules on massive federal 340B drug-pricing program
By Ed Sealover | The Sum & Substance
Many employers know little about the $66 billion 340B federal drug-pricing program and its impact on them. But that likely will change in 2025, when a schism between hospitals and drug makers over the rapid growth of the program will take center stage at the Legislature.
The Colorado Hospital Association is working with a group of lawmakers to introduce a bill early in the session that would prohibit drug manufacturers from limiting the use of the discount program to certain pharmacies. Eight states have passed similar laws and about a dozen others are expected to consider them next year, making it arguably the most divisive health-care debate in America today.
Created in 1992, the 340B program requires pharmaceutical companies participatin...



